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Artemis, a Novel DNA Double-Strand Break
Repair/V(D)J Recombination Protein, Is Mutated
in Human Severe Combined Immune Deficiency
is flanked by recombination signal sequences (RSSs)
composed of conserved heptamers and nonamers sep-
arated by random sequences of either 12 or 23 nucleo-
tides. V(D)J recombination can be roughly divided into
three steps. First, the RAG1 and RAG2 proteins initiate
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is a DNA-dependent protein kinase that belongs to the
phosphoinositol (PI) kinase family, which is recruited at
the site of the DNA lesion through the interaction withSummary
the regulatory complex Ku70/80 that binds to DNA ends
(Gottlieb and Jackson, 1993). Cells from scid mice lackThe V(D)J recombination process insures the somatic
DNA-PK activity owing to a mutation in the DNA-PKcsdiversification of immunoglobulin and antigen T cell
encoding gene (Blunt et al., 1996; Danska et al., 1996).receptor encoding genes. This reaction is initiated by
In the final phase of the V(D)J rearrangement, the DNAa DNA double-strand break (dsb), which is resolved
repair machinery per se will ensure the re-ligation of theby the ubiquitously expressed DNA repair machinery.
two chromosomal broken ends. This last step resemblesHuman T-B-severe combined immunodeficiency as-
the well-known DNA nonhomologous end joining (NHEJ)sociated with increased cellular radiosensitivity (RS-
pathway in the yeast Saccharomyces cerevisiae (re-SCID) is characterized by a defect in the V(D)J recom-
viewed in Haber, 2000). It involves the XRCC4 (Li et al.,bination leading to an early arrest of both B and T
1995) and the DNA ligaseIV (Robins and Lindahl, 1996)cell maturation. We previously mapped the disease-
factors. V(D)J recombination represents a critical check-related locus to the short arm of chromosome 10. We
point in the development of the immune system. Indeed,herein describe the cloning of the gene encoding a
all the animal models carrying a defective gene of either
novel protein involved in V(D)J recombination/DNA re-
one of the known V(D)J recombination factors, either
pair, Artemis, whose mutations cause human RS- natural (murine and equine scid) or engineered through
SCID. Protein sequence analysis strongly suggests homologous recombination, exhibit a profound defect
that Artemis belongs to the metallo-b-lactamase su- in the lymphoid developmental program owing to an
perfamily. arrest of the B and T cell maturation at early stages
(Mombaerts et al., 1992; Shinkai et al., 1992; Nussen-
Introduction zweig et al., 1996; Zhu et al., 1996; Jhappan et al., 1997;
Shin et al., 1997; Barnes et al., 1998; Frank et al., 1998;
B and T lymphocytes recognize foreign antigen through Gao et al., 1998a, 1998b; Taccioli et al., 1998).
specialized receptors: the immunoglobulins and the T A fully defective T cell development program is ob-
cell receptor (TCR), respectively. The highly polymorphic served in a number of rare human conditions denomi-
antigen-recognition regions of these receptors are com- nated severe combined immune deficiency (SCID) (Fi-
posed of variable (V), diversity (D), and joining (J) gene scher et al., 1997). In about 20% of SCID, the phenotype
segments that undergo somatic rearrangement prior to consists of a virtually complete absence of both circulat-
their expression by a mechanism known as V(D)J recom- ing T and B lymphocytes, associated with a defect in
bination (Tonegawa, 1983). Each V, D, and J segment the V(D)J recombination process, while natural killer (NK)
cells are normally present and functional. This condition
is autosomal and recessive. It is lethal within the firstk To whom correspondence should be addressed (e-mail: devillar@
infobiogen.fr). year of life because of the occurrence of multiple and
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Figure 1. Cloning of the Artemis Gene
(A) Schematic representation of the two BAC
contigs, 10ctg23 and 10ctg1105, that con-
tained 15 and 9 BACs (thick bars), respec-
tively. These contigs include the two most
external STS markers defining the RS-SCID
region, D10S1664 and D10S674. The se-
quence accession number corresponding to
each BAC is mentioned on the right (seq.).
The peptide 0083 (see text) was identified in
the AL360083 sequence of clone 2K17 using
both FGENESH and GENESCAN gene predic-
tion softwares.
(B) Scheme of the strategy employed for clon-
ing the Artemis cDNA. See text for explana-
tions.
protracted infections, often caused by opportunistic mi- interest to us as they included several BACs bearing
the RS-SCID region flanking markers D10S1664 andcro-organisms. Allogeneic stem cell transplantation can
cure this immunodeficiency. Mutations in either the D10S674, as well as D10S191 and D10S1653, that
showed the maximum pairwise LOD scores in A-SCIDRAG1 or RAG2 gene account for a subset of patients
with T-B-SCID (Schwarz et al., 1996; Corneo et al., 2000; populations (Li et al., 1998). We initiated a systematic
survey of the nucleotide sequences, covering the 24Villa et al., 2001). In some patients (RS-SCID), the defect
is not caused by RAG1 or RAG2 mutations and is accom- BACs present in these two contigs. The gene analysis
software FGENESH predicted six peptides in the 260panied by an increased sensitivity to ionizing radiations
of both bone marrow cells (CFU-GMs) and primary skin Mb AL360083 nucleotide sequence (07/15/2000 draft
release), derived from the 2K17 BAC. In one of themfibroblasts (Cavazzana-Calvo et al., 1993), as well as a
defect in V(D)J recombination in fibroblasts (Nicolas et (subsequently named “0083” peptide), 121 aa turned out
to be 35% and 31% identical to the MuSNM1 (AAF64472)al., 1998). Although this condition suggests that RS-
SCID could have a general DNA repair defect reminis- and Yeast PSO2 (P30620) proteins, respectively. The
same peptide prediction was obtained using GENE-cent of the murine scid situation, DNA-PK activity was
found normal in these patients and the implication of SCAN. SNM1 and PSO2 are two proteins involved in the
reparation of DNA damages caused by DNA interstrandthe DNA-PKcs gene has been unequivocally ruled out
by genetic means in several consanguineous families cross-linking agents (ICL), including cisplatin, mitomy-
cin C, or cyclophosphamide (Henriques and Moustac-(Nicolas et al., 1996). A role for all the other known genes
involved in V(D)J recombination/DNA repair was equally chi, 1980; Dronkert et al., 2000; and references therein).
Mouse and yeast mutants for SNM1/PSO2 are hyper-excluded as being responsible for RS-SCID condition
(Nicolas et al., 1996, 1998). The gene defective in RS- sensitive to several agents that cause ICLs, but not to
g rays, in contrast to RS-SCID patients. Despite thisSCID, therefore, encodes an as yet undescribed factor.
We recently assigned the disease-related locus to the important discrepancy in the radiosensitivity phenotype,
the putative “0083” peptide-encoding gene representedshort arm of human chromosome 10 in a 6.5 cM region
delimited by two polymorphic markers, D10S1664 and a good candidate owing to its chromosomal localization
and its similarity with DNA repair proteins. A searchD10S674 (Moshous et al., 2000), a region in which the
locus of a similar SCID condition found in Athabascan for RNA transcripts encoding this peptide in the TIGR
Human Gene Indices database (Figure 1B) returned thespeaking American Indians (A-SCID) was also mapped
(Hu et al., 1988; Li et al., 1998). Here we report the THC535641 index within which the AA278590 repre-
sented the most 59 sequence and corresponded to theidentification and cloning of the Artemis gene, localized
in this region of chromosome 10. Artemis codes for a I.M.A.G.E. clone 703546. The nucleotide sequence of
this clone’s opposite end (AA278850) matched thenovel V(D)J recombination/DNA repair factor that be-
longs to the metallo-b-lactamase superfamily and THC483503 index. The AI859962 nucleotide sequence
in this second index provided the most 39 extension ofwhose mutations cause human RS-SCID condition.
the cDNA coding for the “0083” peptide. A complete
cDNA (Figures 1B and 2) was obtained by RT-PCR am-Results
plification of fibroblast RNA using 0083F1 and 169F
primers chosen within the AA278590 and AI859962 nu-Cloning of the Artemis cDNA
Among all the chromosome 10 bacterial artificial chro- cleotide sequences, respectively. The entire cDNA se-
quence of 2354 bp (Figure 2) contains an open readingmosome (BAC) contigs derived at the Sanger center,
10ctg1105 and 10ctg23 (Figure 1A) were of particular frame (ORF) of 2058 bp. The ATG at position 60 is as-
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Figure 2. Artemis cDNA Sequence
The sequence of peptide 0083 is underlined.
It is part of the gray shaded SNM1 homology
domain.
sumed to represent the translational initiation site based consequence of RNA processing, suggesting that this
cDNA may extend further downstream, in accordanceon the analysis of surrounding nucleotides matching the
Kozack consensus for translation initiation, as well as with the transcript size detected on Northern blot (see
below). However, because of this polyA tract, we weresequence comparison with a murine cDNA homolog (not
shown). The encoded protein of 685 aa, which we name unable to further extend the 39 sequence. Functional
complementation studies (see below) strongly suggest,Artemis, has a predicted molecular weight of 77.6 kDa.
The “0083” peptide (underlined in Figure 2) corresponds however, that we have indeed cloned the full Artemis
ORF. The Artemis gene structure (Figure 3) was deducedto I99-H247 and is part of a larger region (gray box) that
shows similarity to scPSO2 and muSNM1. We cannot by comparison of the cDNA sequence to the genomic
(AL360083) sequence. Artemis is composed of 14 exonsfully ascertain that this cDNA represents the full-length
sequence even though repeated attempts to further ex- with sizes ranging from 52 bp to 1160 bp. The exact
length of the Artemis gene is presently unknown as thetend the 59 sequence failed. The polyA tail in the 39
untranslated region of the sequence presented in Figure AL360083 draft sequence is not yet fully contiguous.
Database search with the Artemis protein sequence did2 is encoded by the genomic sequence and is not the
Cell
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Figure 3. Genomic Organization of the Ar-
temis Gene with the Mutations Identified in
RS-SCID Patients
not uncover orthologs in any of the fully sequenced The Artemis Gene Is Mutated in Human RS-SCIDs
We next analyzed the structure and the sequence of theorganisms. However, cDNA cloning of the murine Ar-
temis revealed a 78% protein identity over the whole Artemis gene in a series of 11 RS-SCID families including
13 patients (Table 1; Figure 3). Three patients (P6, P15,sequence (data not shown), which suggests a high de-
gree of conservation among higher eukaryotes. and P40) were characterized by a complete absence of
the Artemis transcript caused by a genomic deletion
extended from exon 1 to exon 4. This mutation can beExpression of Artemis
Increased radiosensitivity of RS-SCID to g rays is not considered as a complete null allele. The same genomic
deletion was present on one allele in P1, who carried arestricted to the cells of the immune system, but is also
a characteristic of fibroblasts, suggesting that Artemis C279T nucleotide change on the other allele that led to
the formation of a nonsense codon at R74. Homozygousis ubiquitously expressed. Northern blot analysis on a
panel of eight different tissues (Figure 4A) confirmed the C279T mutation was also present in P2 and found het-
erozygous in P4. Two other genomic deletions werebroad spectrum of Artemis expression. As discussed
above, the smaller size of the Artermis cDNA compared characteristic of this series of RS-SCID patients. A ho-
mozygous deletion spanning exons 5 to 8 in P47 led toto the main transcript size (4.0 kb) is likely caused by the
reverse transcriptase priming on the genomic encoded the formation of a cDNA in which exon 4 was spliced
in-frame to exon 9, resulting in a putative protein lackingpolyA tract present in the 39 untranslated region. Ubiqui-
tous Artemis expression was further confirmed by PCR K96 to Q219. In P3, a heterozygous genomic deletion
of exons 5 and 6 resulted in the out of frame splicinganalysis on a panel of 15 cDNAs representing a wide
range of hematopoietic and nonhematopoietic tissues of exons 4 to 7, leading to a frameshift at K96. The
second allele in this patient carried a heterozygous G(Figure 4B). The level of Artemis expression is weak
and required 30 PCR cycles (38 cycles for the skeletal to C nucleotide change in the exon 11 canonical splice
donor sequence, which caused the out of frame splicingmuscle) to get an appropriate signal with an internal
P32-labeled oligonucleotide, compared to the strong of exons 10 to 12, leading to a frameshift at T300. Lastly,
three other splice donor sequence mutations were iden-ethidium bromide staining obtained for the control gene
GAPDH. Low level expression of Artemis could reflect tified in six patients. A heterozygous G to A nucleotide
change in the exon 10 splice donor site in P4 gave risea general property of the SNM1 protein family as the
basal expression of mSNM1 in ES cells was found very to the production of a cDNA where the fusion of exons
9 to 12 preserved the open reading frame and potentiallylow as well (Dronkert et al., 2000). Of note, compared
to other tissues, Artemis RNA level is not increased in led to the production of a protein lacking A261 to E317.
Homozygous G to T mutation in the exon 5 donor sitethymus or bone marrow, the sites of V(D)J recombi-
nation. was found in the siblings P5, P11, and P12, as well as
Figure 4. Artemis cDNA Expression
(A) Northern blot analysis. the membrane was successively hybridized with an Artemis and a b-actin probe.
(B) RT-PCR analysis using a commercial panel of cDNA from hematopoietic and nonhematopoietic tissues. GAPDH-specific primers were
used as control.
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Table 1. Mutations of the Artemis Gene in RS-SCID Patients
Patients Mutation Effect Status
P1 Genomic deletion (exons 1–4) No RNA Heteroz.
C279T R74Xa Heteroz
P2 C279T R74X Homoz.
P3 Genomic deletion (exons 5–6) K96 frameshift Heteroz.
Exon 11 splice donor (G!C) T300 frameshift Heteroz.
P4 C279T R74X Heteroz.
Exon 10 splice donor (G!A) Del A254–E317 Heteroz
P5/P11/P12/P38 Exon 5 splice donor (G!T) K96 frameshift Homoz.
P6/P15/P40 Genomic deletion (exons 1–4) No RNA Homoz.
P16 Del G818 A254 frameshift Homoz.
P47 Genomic deletion (exons 5–8) Del K96–Q219 Homoz.
a Stop codon.
in P38, creating the out of frame splicing of exons 4 to the coding ends similar to those obtained in control
fibroblasts (data not shown). Altogether, these results6 and the formation of a frameshift at K96. Although this
form of cDNA lacking exon 5 as a result of an alternative indicate that the V(D)J recombination defect in RS-SCID
is directly related to the described mutations in the Ar-splicing event was also detected at a low level in RNA
from normal cells (data not shown), it accounted for all temis gene and can be complemented by the introduc-
tion of a wt Artemis cDNA in the patients’ fibroblasts.the cDNAs in P5 and P38. In patient P16, a homozygous
deletion of G818 in exon 9, together with a homozygous Although transient high level expression of Artemis did
not seem to be toxic, we could not derive stableC to T change nine nucleotides downstream in the intron,
caused the formation of a frameshift at A254. Whenever transfectants to analyze the complementation of the
hypersensitivity to ionizing radiation. This could reflectsamples of the patients’ parents were available, we
tested them for the presence of the mutations. We could a toxicity of long-term high level expression of wt Ar-
temis in the transfected fibroblasts. An analogous cellu-confirm the inheritance of the mutations in P5, P11, and
P12, as well as P38 and P16, by direct sequencing of lar toxicity was previously noted upon overexpression
of other human or murine homologs of SNM1 in vitrothe exon-specific genomic PCR obtained from parents’
DNA, which concurs with the autosomal recessive inher- and may be a characteristic of this family of proteins
(Dronkert et al., 2000). This is also in agreement withitance. In summary, all of the 13 RS-SCID patients tested
in this series carried homozygous or heterozygous mu- the physiological low level RNA expression of these
genes (see above).tations in the Artemis gene. None of these mutations
were simple missense, and one of them (genomic dele-
tion of exons 1 to 4) can be considered as a true null Artemis Belongs to the Metallo-b-Lactamase
Superfamilyallele given the complete lack of Artemis transcript in
P6, P15, and P40. Database searches using Artemis protein sequence re-
vealed significant similarities to several proteins, includ-
ing the yeast PSO2 and murine SNM1 proteins, over theArtemis Complements the RS-SCID V(D)J
Recombination Defect first 360 amino acids of Artemis (Figure 5 and data not
shown). Subsequent iterations with the PSI-BLAST pro-We previously demonstrated the absence of V(D)J re-
combination-derived coding joint formation in RS-SCID gram highlighted significant similarities of the first 150
amino acids to well-established members of the metallo-patients’ fibroblasts upon transfection of RAG1 and
RAG2 expression constructs together with extrachro- b-lactamase superfamily (Figures 5A and 5B). The me-
tallo-b-lactamase fold, first described for the Bacillusmosomal V(D)J recombination substrates specific for
the analysis of the coding (pHRecCJ) joint (Nicolas et cereus b-lactamase (Carfi et al., 1995), is adopted by
various metallo-enzymes with a widespread distributional., 1998). In contrast, signal joint formation was always
found normal in RS-SCID fibroblasts (Nicolas et al., and substrate specificity (Aravind, 1997). It consists of
a four-layered b sandwich with two mixed b sheets1998; Table 2). We cloned the Artemis cDNA in the mam-
malian expression vector pIres-EGFP and assessed its flanked by a helices, with the metal binding sites located
at one edge of the b sandwich (Figure 5C). Sequencefunctional complementation activity in the V(D)J recom-
bination assay in fibroblasts from seven RS-SCID pa- analysis as well as secondary structure prediction for
Artemis clearly indicated the conservation of motifs typi-tients using the pHRecCJ substrate (Table 2). In all
cases, bacterial blue colonies were repeatedly recov- cal of the metallo-b-lactamase fold. This is true in partic-
ular for the amino acids D10, [HXHKDH]26–31, H108, andered following transfections in the presence of wt Ar-
temis (1), attesting for the RAG1/2 driven recombination D129 (underlined with a star in Figures 5A and 5B and
represented as ball-and-stick in Figure 5C) participatingof the substrate, while virtually no such colonies were
obtained in the absence of exogenous wt Artemis (2). in the metal binding pocket and representing the catalytic
site of the metallo-b-lactamases. The last metal bindingSequence analysis of the recovered pHRecCJ plasmids
forming blue colonies in this assay in fibroblast lines residue of the metallo-b-lactamases, H225 in Tenotropho-
monas maltophilia metallo-b-lactamase (1SML), whichfrom P1 and P40 demonstrated that the junctions were
bona fide V(D)J coding joints with limited trimming of is located at the end of a b strand (strand b12), is appar-
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Table 2. Complementation of V(D)J Coding Joint Formation in RS-SCID Fibroblasts Transfected with wt Artemis
Coding (pHRecCJ) Signal (pHRecSJ)
wt Artemis
Cell Line Plasmid Blue Col. Total Ra Blue Col. Total Rb
50 42,000 3.5 27 10,840 2.5
Control 2
1 16 15,000 3.2
0 34,800 ,0.03 34 45,600 0.7
P1 2
1 23 40,000 1.7
P4 2 2 36,300 0.16 336 98,200 3.4
1 23 54,000 1.3
P5 2 0 21,400 ,0.05 17 3,000 5.7
1 52 61,600 2.5
1 65 16,300 11.9
1 48 10,800 13.3
1 48 20,000 7.2
P15 2 2 11,160 0.53 192 30,000 6.4
1 16 31,200 1.5
P16 2 0 13,000 ,0.08 51 33,200 1.5
1 30 13,680 6.6
P40 2 0 40,250 ,0.02 nd nd nd
1 90 160,000 1.7
1 65 58,800 3.3
1 100 42,840 7.0
1 76 29,736 7.6
P47 2 0 28,200 ,0.003 25 66,800 0.4
1 48 50,000 2.9
a R (coding joints) 5 3 3 (Blue col.)/(Total) 3 1,000.
b R (signal joints) 5 (Blue col.)/(Total) 3 1,000.
ently absent in Artemis/SNM1/PSO2, but could be sub- flanked by the D10S1664 and D10S674 polymorphic
markers, a region too large for classical cDNA selectionstituted for by the aspartic acid D158 of Artemis, also
conserved in SNM1/PSO2. The later residue is located studies (Li et al., 1998; Moshous et al., 2000). Systematic
in silico annotation of draft genomic sequences coveringat the end of a predicted b strand, separated by an a
helix from the strand bearing the preceding metal bind- this region led us to the identification of the Artemis
gene. As expected, given the generalized increased ra-ing residue. However, it is also possible that the last
metal binding residue occurs much farther (H312, Figure diosensitivity in RS-SCID patients’ cells (Cavazzana-
Calvo et al., 1993), Artemis demonstrated a pleiotropic5D), the intervening sequences representing, then, a
large insertion within the metallo-b-lactamase domain expression pattern.
(Aravind, 1997). Altogether, this analysis not only indi-
cates that Artemis probably adopted the b-lactamase Mutations in the Artemis Gene Cause RS-SCID
The first indication that Artemis was indeed the genefold, but may also have conserved an associated cata-
lytic activity, in contrast to several other proteins having involved in the RS-SCID came from the identification of
mutations in several patients. Altogether, eight differentlost many of the catalytic residues (Aravind, 1997).
alterations of the gene were found in 11 families. Al-
though some of the mutations were recurrent, it wasDiscussion
not possible to draw any clear correlation with the geo-
graphical origins of the patients. Several interesting fea-Identification of the Artemis Gene
Genetic studies in humans have changed gear since the tures arise from the analysis of these mutations. First,
three of the identified modifications involve genomicrecent availability of the near complete whole genome
DNA sequence together with the policy of several cen- deletions spanning several exons, leading to frameshift
and appearance of premature terminations in two casesters, such as the Sanger center, to freely distribute, on
a real time basis, their data to the scientific community. and in-frame deletion of 216 aa in one case. This indi-
cates that the Artemis gene may represent a hot spotThe second major contribution to the identification of
the Artemis gene was the development of very powerful for gene deletion. Second, none of the mutations con-
sists of simple nucleotide substitutions generatingprograms (and again their free availability to the scien-
tific community) capable of hunting genes embedded amino acid changes, and only one, the C279T modifica-
tion, creates a nonsense mutation. The other nucleotidewithin megabases of genomic DNA sequences. As an
example of their robustness, the 0083 peptide se- changes affect splice donor sequences leading to either
frameshifts in three cases or to in-frame deletion of partquence, which was recovered from the AL360083 nucle-
otide sequence, is encoded by five different exons, the of the protein in one case. Third, in three patients (P6,
P15, and P40), the genomic deletion comprises exonssplicing of which was correctly predicted by both GENE-
SCAN and FGENESH programs. The RS-SCID was pre- 1 to 4 and results in a complete absence of Artemis-
encoded cDNA. This deletion, which can be consideredviously assigned to a 6.5 cM chromosomal region
Artemis, a DNA-Repair/V(D)J Recombination Protein
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Figure 5. Artemis Belongs to the Metallo-b-Lactamase Superfamily
(A) Alignment of human Artemis, mouse SNM1, and yeast PSO2 amino acid sequences with two metallo-b-lactamases whose three-dimensional
structures were solved (metallo-b-lactamase l1 from Stenotrophomonas maltophilia [Protein Data Bank identifier 1SML; Swiss-Prot identifier
BLA1_XANMA], metallo-b-lactamase from Bacillus cereus [Protein Data Bank identifier 1BVT; Swiss-Prot identifier BLA2_BACCE]). Secondary
structures, as experimentally determined, are reported below the two metallo-b-lactamase sequences and are labeled according to the
representation of the three-dimensional structure of Stenotrophomonas maltophilia metallo-b-lactamase shown in (C). Identical amino acids
appear white on a black background, similar amino acids are boxed (shaded when hydrophobic). Amino acids that participate in metal binding
sites are represented with a star and depicted in a ball-and-stick representation in (C). Motifs 1 and 2 (encircled), typified by a conserved
aspartate ending strand b5 (1SML Asp53) and by the HxHxDH signature (1SML His84, His86, Asp88, and His89), respectively, belong to the
first b sheet of the metallo-b-lactamase fold. Motifs 3 and 4 (encircled) lie in the second b sheet and are characterized by conserved histidine
(His160, preceded by a small residue) and aspartate (or cysteine) (Asp184) residues at the end of strands b9 and b11, respectively.
(B) No significant alignment can be obtained for 1SML helix a3 and strand b12, although a similar succession of secondary structures (a helix
followed by b strand) is predicted for Artemis/SNM1/PSO2. It is worth noting that a conserved aspartate is observed after the predicted b
strand, suggesting that this residue could be present in the active site. The last metal binding histidine (motif 5 in 1SML) could be provided
for by downstream sequences.
(C) Three-dimensional representation of the Stenotrophomonas maltophilia metallo-b-lactamase (Protein Data Bank 1SML), highlighting
conserved residues (ball-and-sticks) depicted in (A) and (B).
(D) A conserved region (the bCASP domain) accompanies the metallo-b-lactamase domain in members of the Artemis/SNM1/PSO2 subfamily.
as resulting in a null allele, therefore demonstrates that at least two reasons. First, despite their SNM1 similarity
regions, the three proteins differ in their associated do-Artemis is not an essential protein for viability, in con-
trast to XRCC4 and DNA ligaseIV for example (Barnes mains. In particular, the 331 amino acids composing the
C-terminal region of Artemis are not present in SNM1/et al., 1998; Frank et al., 1998; Gao et al., 1998b), or that
it is partly redundant. This information is of particular PSO2 and do not show any obvious similarities with any
other known protein. Second, while murine and yeastinterest in the setting of a murine knockout counterpart
to the human RS-SCID condition. Lastly, the implication SNM1/PSO2 mutants demonstrate a strong defect in
the repair of DNA damages caused by DNA interstrandof Artemis in the RS-SCID condition was unequivocally
established by complementation of the V(D)J recombi- cross-linking agents (Henriques and Moustacchi, 1980;
Dronkert et al., 2000), they do not display elevated sensi-nation defect in patients’ fibroblasts upon transfection
of a wt Artemis cDNA. tivity to ionizing radiations, indicating that these two
proteins are probably not directly involved in the repair
of DNA dsb. This is in sharp contrast to the phenotypeArtemis Function
Although we can infer from the phenotype of RS-SCID of RS-SCID patients whose primary molecular defect is
indeed the absence of DNA dsb repair, illustrated bypatients that Artemis is part of the ubiquitous machinery
involved in DNA dsb repair that is shared by the V(D)J the lack of coding joint formation in the course of V(D)J
recombination and the increased sensitivity of bonerecombination process, the precise function for this new
factor remains to be defined. The repeated search for marrow and fibroblast cells to g rays (Cavazzana-Calvo
et al., 1993; Nicolas et al., 1998). Interestingly, Artemis,a global ortholog of both human and murine Artemis in
other species in protein databases failed to provide a murine SNM1, and yeast PSO2 share a domain adopting
a metallo-b-lactamase fold (Aravind, 1997) and possiblystrong candidate, and we are left with the initial similarity
of the 0083 peptide, which includes the whole N terminus its associated enzymatic activity, given the presence of
nearly all the critical catalytic residues (or conservedmoiety of Artemis, to the various members of the SNM1
family (Figure 5). However, Artemis is clearly not the residues which could substitute for them for function).
However, there is no obvious consensus with regard tohuman ortholog of either murine SNM1 or yeast PSO2 for
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the nature of the various metallo-b-lactamase sub- In conclusion, we described the identification and
strates, outside of a general negatively charged compo- cloning of the gene coding for Artemis, a novel actor
sition. Sequence analysis revealed the existence of a of the V(D)J recombination. Mutations of Artemis are
conserved region that accompanies the metallo-b-lacta- causing T-B-SCID defects in humans owing to an ab-
mase domain in members of the Artemis/SNM1/PSO2 sence of repair of the RAG1/2-mediated DNA double-
subfamily (Figure 5D and data not shown), including strand break. Artemis belongs to a large family of mole-
various other sequences related to nucleic acid metabo- cules that adopted the metallo-b-lactamase fold as part
lism, such as two subunits of the cleavage and polyade- of their putative catalytic site. One branch of this family,
nylation specificity factor (CPSF). We propose to name which also includes yeast SNM1 and murine PSO2, has
this domain, which we will describe in detail elsewhere, appended another domain, which we name bCASP, that
bCASP for metallo-b-lactamase associated CPSF Ar- may target the activity of this subgroup of proteins to-
temis SNM1/PSO2 domain. This domain, although ward nucleic acids and, thus, serves the purpose of DNA
highly divergent and tolerating multiple insertions (e.g., repair. Finally, other domains, yet to be defined, are
within yeast PSO2 in Figure 5D), harbors several con- probably responsible for directing the various Artemis/
served residues that could play a role in the reaction SNM1/PSO2 proteins to their specific DNA repair path-
catalyzed by members of this subfamily. It is tempting to ways, the dsb repair for Artemis or the DNA-ICL repair
speculate that this domain could contribute to substrate for SNM1/PSO2.
binding, in a similar way as the a-helical domain of glyox-
alase, another member of the b-lactamase family (Cam- Experimental Procedures
eron et al., 1999).
Patients and Cells
13 RS-SCID patients from 11 families were analyzed in this studyArtemis in the NHEJ Pathway of DNA Repair
having been selected for their typical phenotype of autosomal reces-DNA dsb can be repaired either by homologous recom-
sive SCID with complete absence of peripheral T and B lymphocytes,bination (HR) or by the nonhomologous end joining path-
but presence of natural killer cells (Fischer et al., 1997). All the
way (NHEJ) (reviewed in Haber, 2000). While HR is the patients showed an impaired V(D)J recombination assay in fibro-
predominant repair pathway in yeast, NHEJ is mostly blasts, and for all RS-SCID families except P16, P40, and P47, radio-
utilized in higher eukaryotes and represents the DNA sensitivity status could be determined on bone marrow cells and/
or fibroblasts (Cavazzana-Calvo et al., 1993; Nicolas et al., 1998;repair pathway followed during V(D)J recombination. At
Moshous et al., 2000; and our unpublished results). Genotypingleast two protein complexes are thought to act in con-
of the consanguineous families using polymorphic microsatellitecert or sequentially at the site of the RAG1/2-derived
markers, as reported elsewhere (Moshous et al., 2000), concurred
dsb. The Ku70/80 complex is probably recruited first at in every case with our previously described localization of the RS-
the site of the lesion, followed by the addition of the SCID gene on chromosome 10p. We studied four patients of French
DNA-PKcs subunit. This initial complex is considered origin (P1, P3, P6, and P15), one of which (P15) was born to related
parents, one was of Italian origin (P16), one Greek (P4), and oneas the primary DNA damage sensor that will activate
African (P2). The remaining patients originate from four consanguin-the DNA repair machinery. The XRCC4/DNA ligaseIV
eous Turkish families, two of them being related (P38, P5, P11, andrepresents the best candidate to actually repair the gap.
P12, respectively). Informed consent was obtained from the familiesOne would like to know of course how Artemis inter-
prior to this study. Primary fibroblast cell lines were derived from
venes in this cascade. At this point, we can only provide skin biopsies and pseudo-immortalized with SV40 as described
hypotheses based upon the analogy of phenotypes be- elsewhere (Nicolas et al., 1998) and cultured in RPMI 1640 (GIBCO
tween the various V(D)J recombination-deficient models BRL) supplemented with 15% fetal calf serum.
including the RS-SCID. Two major differences exist be-
tween the RS-SCID condition and the XRCC4 and DNA Artemis cDNA Cloning and Genomic Amplification
ligaseIV KO mice. First, a complete null allele of Artemis Chromosome 10 BAC contigs were established by the “Chr10 map-
ping group” at Sanger center (http://www.sanger.ac.uk/HGP/(such as in P6, P15, and P40) does not lead to embryonic
Chr10). The Chr10 sequences were released by the “Chr10 sequenc-lethality in humans in contrast to the murine situation.
ing group” at Sanger center (http://webace.sanger.ac.uk/cgi-bin/This observation therefore does not support an implica-
ace/simple/10ace).tion of Artemis in this phase of NHEJ. Second, the re- Our cloning strategy was based on in silico nucleotide sequence
joining of linearized DNA constructs introduced in RS- annotation with GENESCAN (Burge and Karlin, 1997) and FGENESH
SCID fibroblasts is not altered (unpublished results) (Salamov and Solovyev, 2000) softwares, two programs aimed at
while this assay, when defective, is highly diagnostic of searching for putative peptide encoding genes in large genomic
DNA sequences. Artemis full-length coding sequence was amplifiedabnormal NHEJ in yeast (Teo and Jackson, 1997; Wilson
by polymerase chain reaction (PCR) on cDNA, obtained from reverseet al., 1997). Perhaps the most evident link between
transcribed fibroblast total RNA, using the Advantage-GC cDNAArtemis and NHEJ is found in regard to the Ku/DNA-
PCR Kit (Clontech) according to the manufacturers’ recommenda-
PK complex. Indeed, human RS-SCID patients and scid tions and 0083F1 (59-GATCGGCGGCGCTATGAGTT-39) and 169F
mice, which harbor a mutation in the DNA-PKcs encod- (59-TGTCATCTCTGTGCAGGTTT-39) primers designed from the
ing gene, are the only two known conditions where a AA278590 and AI859962 EST sequences (see Results section). The
V(D)J recombination-associated DNA repair defect af- PCR products were sequenced directly on an ABI377 sequencer
(Perkin-Elmer) using BigDyeTerminator Cycle Sequencing Readyfects uniquely the formation of the coding joints, leaving
Reaction (Applied Biosystems) with a series of internal oligonucleo-signal joint formation unaltered, which is in striking con-
tides. Artemis cDNA was subcloned into pIRES-EGFP (Clontech) fortrast with all the other known V(D)J recombination/DNA
subsequent use in transfection experiments. Genomic structure of
repair deficiency settings. This raises the interesting the Artemis gene was deduced by alignment of the cDNA sequence
possibility that Artemis, through its possible hydrolase to the draft sequence of the Bac 2K17 (AL360083). Series of oligonu-
activity, may participate in opening the hairpin at the cleotide primer pairs were designed for the specific amplification of
each exon: Ex1F1 59-CTCCGGACTCCTCTGATTGG-39; Ex1R1 59-GGGcoding ends.
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